Benzinga | Jul 20, 2021 12:12PM EDT

SVB Leerink Maintains Outperform on Edwards Lifesciences, Raises Price Target to $125

SVB Leerink analyst Danielle Antalffy maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $106 to $125.